BACKGROUND/OBJECTIVE: Recent epidemiological data have shown that abdominal fat accumulation is associated with increased risk of cardiovascular events in patients with chronic kidney disease (CKD). This study aimed to investigate the association between visceral adiposity and coronary artery calcification (CAC) in CKD patients. SUBJECTS/METHODS: Cross-sectional study with 65 nondialyzed CKD male patients (59±9 years, CKD stages 3 and 4). Abdominal fat compartments were assessed by computed tomography (CT) at L4-L5 level. Visceral to subcutaneous (V/S) fat ratio was calculated. Visceral obesity was defined as a V/S fat ratio greater than the median value of the sample study (40.55). CAC was detected by multi-slice CT. CAC scores were calculated with the Agatston method. RESULTS: CAC was present (calcium score 410 AU) in 66% of patients. In the group with visceral obesity, the CAC score was significantly higher. This group had lower adiponectin and higher leptin levels compared to patients without visceral obesity. In the whole sample, higher V/S fat ratio was associated with CAC score, independently of age, body mass index, diabetes, ionized calcium, smoking or renal function. CONCLUSION: Our results show an association between visceral obesity and CAC in CKD patients, suggesting a deleterious effect of visceral fat in these patients. Increased visceral adiposity might enhance cardiovascular risk in this particular population.
INTRODUCTION
Patients with chronic kidney disease (CKD) have a high prevalence of vascular calcification, especially coronary artery calcification (CAC), a measure of subclinical atherosclerosis. 1 The calcification process begins in the early stages of the disease 2, 3 and has been associated with cardiovascular morbidity and mortality in these patients. 4 Metabolic abnormalities such as insulin resistance and dyslipidemia and chronic low-grade inflammation are highly prevalent in CKD patients and have been implicated in the pathogenesis of CAC. [5] [6] [7] Obesity states including abdominal obesity share many of the abnormal metabolic conditions seen in CKD patients. [8] [9] [10] There is evidence that vascular calcification, including CAC, is associated with abdominal obesity in the general population. [11] [12] [13] However, the mechanistic link between abdominal obesity and vascular calcification is not clearly identified. Accumulation of adipose tissue in the abdominal region is found in a high proportion of CKD patients and has been associated not only with cardiovascular risk factors 14 but also with cardiovascular events and mortality. [15] [16] [17] The adipose tissue is able to secrete bioactive peptides known as adipokines, such as leptin, adiponectin and resistin. 8, [18] [19] [20] [21] Adipokines have been associated with CAC. 5, 22 We hypothesized that a relationship might exist between CAC and visceral obesity in nondialysis CKD patients, and we discussed a possible role for adipokines.
MATERIALS AND METHODS

Study population
The study sample comprised a total of 65 male nondialyzed CKD patients in stages 3 and 4 consecutively seen at the outpatient clinic of the Federal University of São Paulo, Brazil. Exclusion criteria were: having been followed by nephrologists for less than 3 months, age below 18 years, use of corticosteroids, presence of chronic inflammatory disease, active malignancy, presence of serum-positive human immunodeficiency virus and viral hepatitis. Patients were on regular use of angiotensin-converting enzyme inhibitors (91%), beta-blockers (57%), angiotensin-receptor blockers (23%), diuretics (83%) and insulin (21%).
Written informed consent was obtained from all participants for the purposes of the present study that was in accordance with the Declaration of Helsinki and was approved by the University Ethical Advisor Committee.
Study design
This was a cross-sectional study. Demographic, anthropometric and laboratorial data were initially collected and within 1-2 weeks all patients underwent abdominal scan and coronary computed tomography (CT). Anamnesis focusing on clinical characteristics, comorbidities, familial and personal disease history and surgical procedures was obtained. All measurements were performed within 1 month from the enrollment date.
Laboratory analysis
Blood samples were drawn in a fasting state. Serum parameters included determinations of creatinine, ionized calcium, phosphate, alkaline phosphatase, bicarbonate, sodium, potassium, lipid profile and albumin. Intact parathyroid hormone level was determined by chemiluminescence immunoassay and high-sensitivity C-reactive protein levels by immunometric assay (Immulite, DPC-Biermann, Hessen, Germany). Interleukin 6, leptin and adiponectin were determined by ELISA (Linco Research, MO, USA). Glomerular filtration rate was estimated by using the modification of diet in renal disease study equation. 23 Insulin resistance was estimated by means of homeostasis model assessment index using the equation described elsewhere.
Nutritional assessment
Body mass index (BMI) was calculated for all patients. Overweight/obesity was defined as BMI X25 kg/m 2 . Nutritional status was evaluated by means of a 7-point subjective global assessment questionnaire. 25 DEXA was performed using a Lunar DPX Bone Densitometer scanner (Lunar Radiation Corporation, Madison, WI, USA) with the patient in supine position.
Visceral and subcutaneous fat areas were measured by means of CT (Helical Picker PQ 5000, Cleveland, OH, USA). 26 The subjects were examined in the supine position with both arms stretched above the head. One acquisition was made at L4-L5 level, with a slice thickness of 10 mm and time of exposition varying from 3 to 11 s. Total adipose tissue areas were then calculated by delineating the abdomen with an electronic graph pen and computing the adipose tissue surface by using an attenuation range of -150 to -50 Hounsfield units. Visceral fat was distinguished from subcutaneous fat by tracing along the fascial plane defining the internal abdominal wall. The area of each compartment was measured in square centimeters. V/S fat area ratio was calculated. A ratio greater than the median value of the cohort (0.55) was defined as visceral obesity. Previous observation on our patients showed that visceral obesity based on a V/S fat ratio cutoff greater than 0.55 was a predictor of cardiovascular events. 17 
CAC scoring
Patients underwent CAC quantification by a multi-slice CT scanner (LightSpeed Pro 16, E Healthcare, Milwaukee, WI, USA), using a gantry rotation of 0.4 s, collimation of 2.5 mm (slice thickness) and reconstruction time of 6 frames per second. A calcium threshold of 130 or more Hounsfield units was used. The images were scored by a single radiologist blinded to the clinical and biochemical aspects of the patient. As described by Agatston, the calcium score was determined by multiplying the area of each calcified lesion by a weighting factor corresponding to the peak pixel intensity for each lesion. 27 The sum of each lesion of all coronary arteries was used for analysis. Presence of calcification was defined as a CAC score 410 Agatston units (AU) and severe calcification as a CAC score X400 AU.
Statistical analysis
Variables are shown as mean and standard deviation, median and interquartiles values, or frequency and proportion. Student's t or MannWhitney tests were used to compare groups of patients with and without visceral obesity. Spearman correlation test was used to assess the strength of association between CAC score and the V/S fat ratio, as well as the association between adipokines. Subsequently, multivariate linear regression analysis was performed to analyze whether visceral obesity was associated with calcium score. The calcium score was z-score transformed. A P-value o0.05 was considered statistically significant. All statistical analysis was performed using SPSS for Windows (version 17; SPSS, Chicago, IL, USA).
RESULTS
Patient characteristics
The main demographic, clinical, and laboratorial characteristics of all patients are described in the first column of Table 1 . Forty-five patients (69%) were in stage 3 and 20 (31%) in stage 4 of CKD. The primary causes of kidney disease were hypertension (35%) and diabetes (25%). The majority of the patients were well-nourished according to subjective global assessment. BMI X25 kg/m 2 was found in 39%. CAC was observed in 43 patients Abbreviations: eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; HOMA index, homeostasis model assessment index; IL-6, interleukin-6; LDL-C, low-density lipoprotein cholesterol; n.a., not applicable; PTH, intact parathyroid hormone. Results are expressed as mean ± s.d., median (interquartiles) or n (%).
Visceral obesity and coronary calcification in CKD C Aoqui et al (66%) with a median calcium score of 334 AU (86-850) and among these, 19 patients (44%) had severe calcification with a median calcium score of 867 AU (648-1975).
Association of visceral obesity and CAC Patients were divided into two groups according to the V/S fat ratio (Table 1 ). In the group with visceral obesity (V/S 40.55), there was a higher prevalence of history of smoking, higher values of ionized calcium, albumin, leptin and BMI. Coronary calcification score was significantly higher in this group. There was a trend of higher levels of low-density lipoprotein-cholesterol and HOMA index. Lower values of high-density lipoprotein-cholesterol and adiponectin were also observed in the group with visceral obesity. As expected, leptin and adiponectin were inversely related to each other (r ¼ À 0.30, P ¼ 0.018) and strongly associated with the V/S fat ratio (leptin-V/S: r ¼ 0.38, P ¼ 0.002; adiponectin-V/S: r ¼ À 0.33, P ¼ 0.006). There was a negative correlation of HDL cholesterol levels and V/S fat ratio (r ¼ À 0.29, P ¼ 0.02). No other significant correlation was observed.
In the univariate analysis, calcium score was significantly associated with age (r ¼ 0.51; P ¼ 0.002) and V/S fat ratio (r ¼ 0.24; P ¼ 0.04). No association was observed between calcium score and estimated glomerular filtration rate, mineral metabolism, inflammatory parameters, lipid profile or other nutritional markers. The relation between calcium score and V/S fat ratio in the entire population and only in those with calcification is depicted in Figures 1 a and b , respectively. Diabetic patients had higher calcium score compared to nondiabetic ones [389 AU (22-893) vs 37 AU (0-334); P ¼ 0.016)]. In the multivariate linear regression analysis, after adjustment for age, diabetes, BMI X25 kg/m 2 , estimated glomerular filtration rate, serum ionized calcium and smoking, the presence of visceral obesity was independently associated with coronary calcium score ( Table 2) .
DISCUSSION
In the current study, we found an association between increased visceral adiposity and CAC in CKD patients. To the best of our knowledge, this association has not yet been described.
Studies in the general population have shown that abdominal fat is associated with vascular calcification. [11] [12] [13] In the Framingham Heart Study including 3130 subjects of both genders, general measures of obesity and measures of abdominal fat by means of CT were associated with CAC and abdominal aortic calcium levels, although such associations were attenuated by other cardiovascular disease risk factors. 28 Similarly, an association between visceral fat and CAC was reported in Japanese subjects who underwent CT for investigation of coronary heart disease. Visceral fat area assessed by CT was found to be an independent predictor of the presence and extent of CAC. 29 In the setting of CKD, accumulation of visceral fat determined by CT has been reported to be associated with vascular alterations such as arterial stiffness 30, 31 and carotid artery intima--media thickness 30, 32 in dialysis patients. Increase of visceral fat was also reported to be associated with the presence of carotid atherosclerosis plaque in hemodialysis. 33 In peritoneal dialysis patients, visceral fat thickness assessed by ultrasound was independently associated with carotid atherosclerosis. 34 As far as we know, there are no studies with patients in the nondialysis stage of CKD that have evaluated the relationship between visceral fat alone or V/S ratio and vascular calcification. Visceral obesity and coronary calcification in CKD C Aoqui et al
In our study, the ratio between visceral and subcutaneous fat was chosen in order to assess more accurately the role of visceral fat, particularly when it predominates over subcutaneous fat. A V/S fat ratio X0.4 was reported to be strongly related to metabolic disturbances in obese patients with normal kidney function. 35 However, since our cohort comprised not only obese individuals, and the cutoff for CKD patients has not yet been defined, we chose to use the V/S median value (0.55), which has been recently shown by our group to be a predictor of cardiovascular events. 17 Actually, by using this cutoff, we found that visceral obesity was associated with coronary calcification, a predictor of coronary events 36, 37 We also confirmed the high prevalence of coronary calcification (66%) in CKD patients. We did not find correlation between BMI and CAC, corroborating the results obtained by Marques et al. 38 in 125 subjects referred to perform coronary CT in whom only visceral fat area, not BMI, was an independent marker of coronary disease.
Obesity itself leads to a state of chronic low-grade inflammation and different fat regions can have distinct biochemical characteristics. 39 The accumulation of visceral fat tissue in CKD can work as an additional burden for the already increased inflammatory state in this population. 40 In fact, an upregulated inflammation was reported in the adipose tissue of obese patients with CKD stages 3-4. 41 In our cohort, the inflammatory markers were not different between the groups. The tendency of better kidney function in the patients with visceral obesity could explain, at least in part, the lack of higher C-reactive protein and interleukin 6 levels in this group.
Adipokine secretion by adipose tissue could be involved in the pathogenesis of vascular calcification. 5, 22 As expected, the group of visceral obesity had higher levels of leptin. It has been shown that leptin directly correlates with obesity, insulin resistance and several other cardiovascular disease risk factors such as hypertension, atherosclerosis and pro-inflammatory effects. 42 In the SIRCA (study of inherited risk of coronary atherosclerosis) study, leptin was reported to be an independent predictor of CAC score. 5 Furthermore, leptin was reported to have a direct effect on the vascular smooth muscle cell, regulating its osteoblastic differentiation and calcification. 43, 44 In contrast, adiponectin is the adipokine that has been shown to have a protective role against atherosclerosis, including antiinflammatory, vasculoprotective and antidiabetic effects in the general population. 21 In dialysis patients, a predictive value of leptin and adiponectin for all-cause and cardiovascular death has been reported, depending on abdominal obesity. 45 In our population of nondialysis patients, we observed an association of visceral obesity with lower adiponectin levels, in accordance with a study in hemodialysis patients, in which plasma adiponectin correlated negatively with visceral fat. 46 Moreover, adiponectin was reported to have an inhibitory action on the osteoblastic differentiation of vascular smooth muscle cells, therefore having a protective role in vascular calcification. 47 Taken together, our findings suggest that the accumulation of visceral fat might represent an extra burden on the high prevalence of coronary calcification in CKD patients.
In summary, male CKD patients with higher proportion of visceral fat, independent of BMI, showed association with higher CAC scores. Our observations suggest a deleterious role of visceral fat in CKD patients, which might contribute to increase the cardiovascular risk in this population in either a cause-effect or a synergistic relationship. This is a preliminary study, and further investigations in larger samples of patients are needed in order to better understand the contribution of visceral fat to the high prevalence of vascular calcification in CKD patients.
